MoneyWorks4Me

A decent increase of about 33.68% in the sales to Rs. 919.77 millions was observed for the quarter ended March 2024. The sales figure stood at Rs. 688.04 millions during the year-ago period.The Total Profit for the quarter ended March 2024 of Rs. 44.96 millions grew from Rs.-73.55 millionsOperating profit for the quarter ended March 2024 rose to 214.42 millions as compared to 129.79 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 919.77 688.04 33.68 3071.72 2509.95 22.38 3071.72 2509.95 22.38
Other Income 5.83 14.60 -60.07 18.30 29.41 -37.78 18.30 29.41 -37.78
PBIDT 214.42 129.79 65.21 684.63 632.29 8.28 684.63 632.29 8.28
Interest 30.57 16.68 83.27 103.87 60.20 72.54 103.87 60.20 72.54
PBDT 112.86 -52.18 -316.29 509.77 406.80 25.31 509.77 406.80 25.31
Depreciation 50.43 44.16 14.20 195.11 149.19 30.78 195.11 149.19 30.78
PBT 62.43 -96.34 -164.80 314.66 257.61 22.15 314.66 257.61 22.15
TAX 17.47 -22.79 -176.66 74.83 62.93 18.91 74.83 62.93 18.91
Deferred Tax 1.76 1.67 5.39 -4.37 1.37 -418.98 -4.37 1.37 -418.98
PAT 44.96 -73.55 -161.13 239.83 194.68 23.19 239.83 194.68 23.19
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 23.31 18.86 23.58 22.29 25.19 -11.52 22.29 25.19 -11.52
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..